pocketful logo light
pocketful logo light
Aarti Pharmalabs Ltd logo

Aarti Pharmalabs Ltd

NSE: AARTIPHARM BSE: 543748

₹691.80

(5.06%)

Sun, 21 Jun 2026, 06:13 pm

Aarti Pharmalabs Share Price Live Chart

1 Day

(5.06%)

No Result Found

Summary

  • Market Cap (in Cr)

    5754.5

  • Net Profit (in Cr)

    272.4

  • P/B

    3.41

  • Sector P/E

    33.76

  • P/E

    24.90

  • EV/EBITDA

    15.15

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    14.54

  • ROCE

    17.35

  • Debt/Equity

    0.19

  • EPS (TTM)

    19.50

  • Dividend Yield

    0.55

  • Book Value

    234.35

  • Interest Cover

    14.41

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters43.0843.1042.8843.7244.29
FII8.397.688.027.357.36
DII7.417.666.967.797.53
Public41.1141.5442.1341.1240.81
Government0.010.010.010.010.01

Read More

Technical Analysis

RSI

57.99

MACD

-10.02

50 DMA

689.79

200 DMA

746.19

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1067.08879.08756.17691.08568.17503.08315.08
Fibonacci879.08807.27762.90691.08619.27574.90503.08
Camarilla684.95667.72650.48691.08616.02598.78581.55

Pivots Level: Classic

R3

+376.00

1067.08

R2

+188

879.08

R1

+65.08

756.17

691.08
691.08
Pivot Point
LTP: 691.80

S1

-122.92

568.17

S2

-188

503.08

S3

-376

315.08

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    651.87

  • 20-EMA

    656.61

  • 30-EMA

    664.49

  • 50-EMA

    675.54

  • 100-EMA

    696.58

  • 200-EMA

    722.93

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
25 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
18 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
09 Feb 2026board-meetingsQuarterly Results, Interim Dividend
09 Feb 2026dividend₹1.50 Dividend /Share16 Feb 2026
16 Jan 2026dividendInterim Dividend - Rs. - 1.516 Feb 2026
09 Nov 2025board-meetingsQuarterly Results
29 Aug 2025agm
15 Aug 2025dividendFinal Dividend - Rs. - 2.515 Sept 2025
10 May 2025dividend₹2.50 Dividend /Share15 Sept 2025
05 Feb 2025dividend₹2.50 Dividend /Share14 Feb 2025

Read More

Peer Comparison

Aarti Pharmalabs Ltd logo

Aarti Pharmalabs Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Aarti Pharmalabs Ltd About

Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2019

Headquarters

CEO

Rashesh C Gogri

Employees

Contact

Website icon

Website

https://www.aartipharmalabs.com

Email icon

Email

co.apl@aartipharmalabs.com ; investorrelations@aar

Phone icon

Phone

91-22-6797 6666

Location icon

Location

Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195

Read More

Aarti Pharmalabs Ltd Company History

YearHistory
2019
  • The Company was incorporated as a public limited company under the Companies Act, 2013.
2021
  • The Company name was changed from Aarti Organics Limited to Aarti Pharmalabs Limited.
2022
  • NCLT approved the Scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited.
  • Pharma business of Aarti Industries Limited was vested into the Company.
2025
  • Aarti Pharmalabs Ltd. Credit Rating was upgraded to CRISIL AA-/Stable.
  • Aarti Pharmalabs earned an EcoVadis Gold Rating for sustainability.
  • Aarti Pharmalabs achieved a key sustainability milestone with approval of GHG Emission Reduction Targets by SBTi.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFbulkBuy521613930.3419 Sept 2025
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBALbulkBuy484643930.3219 Sept 2025
SAFECHEM ENTERPRISES PRIVATE LIMITEDbulkSell600000929.1919 Sept 2025
BNP PARIBAS FINANCIAL MARKETSbulkSell45943892919 Sept 2025
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy561058930.3419 Sept 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell848700742.1907 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy848700742.0407 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy854861706.6806 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell854861704.9406 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy776227675.1727 Dec 2024

Read More

Aarti Pharmalabs Ltd News

Aarti Pharma Labs Q4 Profit Falls to 611M Rupees YoY

Aarti Pharma Labs reports Q4 consolidated net profit of 611M Rupees vs 883M YoY. EBITDA declined to 1.1B Rupees; margin contracted to 19.42% from 25.39%.

25 May 2026

companies

AARTI PHARMALABS investor meeting on May 28

AARTI PHARMALABS LIMITED will meet investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode.

20 May 2026

companies

Aarti Pharmalabs Q4 FY26 call

Aarti Pharmalabs Limited has scheduled an earnings conference call for May 26, 2026, to discuss its Q4 FY26 financial results. The meeting will be held at 4:00 PM IST.

20 May 2026

companies

Aarti Pharmalabs Board Meet Rescheduled to May 25, 2026

Aarti Pharmalabs postpones its Board meeting from May 18 to May 25, 2026, to consider Q4 and FY26 audited results and final dividend. Trading Window closed till May 27, 2026.

14 May 2026

companies

Aarti Pharmalabs Board Meet Set for May 18, 2026

Aarti Pharmalabs schedules Board meeting on May 18, 2026 to consider audited financial results for Q4 and FY26, and recommend final dividend, if any.

11 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number